Call Girls Kolkata Kalikapur 💯Call Us 🔝 8005736733 🔝 💃 Top Class Call Girl Se...
Dioxines, PCB, Furanes et DR-CALUX
1. Groupement romand de médecine,
d’hygiène et de sécurité au travail
Journée de présentation de cas
02 octobre 2014
Exposition aux PCB et Dioxines, qu’en
pense le Dr CALUX ?
Vincent PERRET
Hygiéniste du travail certifié SSHT
Hygiène du travail
Toxicologie industrielle
2. Les PCB quelques points
PolyChloroBiphenyles
209 congénères
2
• Liquides visqueux
• Stables à la chaleur, inertes chimiquement
• Isolant électrique
• Très liposoluble et s’accumulent dans le long de la chaîne alimentaire
• Perturbateurs endoctriniens
• Cancérogènes probables (IARC 2a)
6. Exemples d’application des
PCB
Joints de
séparation
(coupure)
entre
bâtiments
Joints de
raccordement
Joints entre
éléments
Joints de retrait
Joints dans bâtiment (1955-1975)
< 200’000 ppm (20%)
6
10. Exemples d’application des
PCB
10
Eléments en amiante
ciment
Nombreux cas de
contamination
d’oeufs aux PCBs
dans des fermes du
nord de la Hollande
et d’Allemagne
13. Toxicité relative des
composés dioxines,
furanes et PCB-dl
Facteurs
d’équivalence
toxique relatif au
2,3,7,8- TCDD
13
14. Les grand évènements
impliquant PCBs et dioxines
¡ 1953 Ludwigsfhaven BASF
¡ 1960’ Vietnam, Agent Orange
¡ 1968 Yusho, Japon
¡ 1976 Seveso ICMESA
¡ 2004 Ukraine, Viktor Iouchtchenko
14
Liste non exhaustive, ne manquez pas le prochain épisode
15. SEVESO 15
A : Teq TCDD 15.5 – 580 μg/m2
B : Teq TCDD < 5 μg/m2
C : Teq TCDD < 1.5 μg/m2
Dégâts :
- Fort impact sur végétaux et
animaux (oiseaux)
- Environ 200 cas de chloracné
(88% enfants)
- Modification du sex ratio dans la
région (filles +)
- Augmentation de cancer sujette
à débat
16. Hamster
Golden Syrian
Face à la dioxine,
qui est le plus fort ?
Cochon d’inde
Hartley
16
18. Effets aigüs
Le cas Iouchtchenko
2000 2004 Empoisonnement
au TCDD de Viktor
Iouchtchenko (alors
premier ministre
ukrainien)
(6 sept 2004)
18
19. TOXICOLOGICAL SCIENCES 125(1), 310–317 (2012)
doi:10.1093/toxsci/kfr223
Advance Access publication October 13, 2011
19
The Cutaneous Lesions of Dioxin Exposure: Lessons from the Poisoning
of Victor Yushchenko
Jean-Hilaire Saurat,*,†,1 Guerkan Kaya,*,† Nikolina Saxer-Sekulic,*,† Bruno Pardo,* Minerva Becker,‡ Lionel Fontao,†
Florence Mottu,*,† Pierre Carraux,† Xuan-Cuong Pham,† Caroline Barde,† Fabienne Fontao,* Markus Zennegg,§
Peter Schmid,§ Olivier Schaad,{ Patrick Descombes,{ and Olivier Sorg*,†
*Swiss Centre for Applied Human Toxicology, Dermatotoxicology Unit, University of Geneva, 1211 Geneva 4, Switzerland; †Dermatology Department and
‡Radiology Department, Geneva University Hospital, 1211 Geneva 14, Switzerland; §EMPA (Swiss Federal Laboratories for Materials Testing and Research),
8600 Du¨bendorf, Switzerland; and {Genomics Platform, National Center of Competence in Research Frontiers in Genetics, University of Geneva, 1211
Geneva 4, Switzerland
1To whom correspondence should be addressed at Swiss Centre for Applied Human Toxicology, University of Geneva, 1, rue Michel-Servet, 1211 Gene`ve 4,
Switzerland. Fax: 0041-22-379 5502. E-mail: jean.saurat@unige.ch.
Received August 10, 2011; accepted August 10, 2011
Several million people are exposed to dioxin and dioxin-like
characterization of dioxin exposure remains difficult to establish,
… pour la Science
20. of sampling were prepared as previously reported (Sorg et al., 2008). RNA
TOXICOLOGICAL SCIENCES 125(1), 310–317 (2012)
quality doi:10.1093/toxsci/was kfr223
assessed using an Agilent 2100 Bioanalyzer with an RNA 6000
Advance Access publication October 13, 2011
Nano LabChip kit. We generated a hybridization mixture containing 15 lg of
biotinylated complementary RNA and hybridized it to GeneChip HG U133
Plus 2.0 according to manufacturer’s instructions (Affymetrix). To identify
differentially expressed transcripts, comparisons were carried out after
normalization with the Affymetrix GCOS 1.2 (MAS5) software.
The Cutaneous Lesions of Dioxin Exposure: Lessons from the Poisoning
of Victor Yushchenko
Jean-Hilaire Saurat,*,†,1 Guerkan Kaya,*,† Nikolina Saxer-Sekulic,*,† Bruno Pardo,* Minerva Becker,‡ Lionel Fontao,†
Florence Mottu,*,† Pierre Carraux,† Xuan-Cuong Pham,† Caroline Barde,† Fabienne Fontao,* Markus Zennegg,§
Bioinformatic analysis. Responsive elements for genes corresponding to
Peter Schmid,§ Olivier Schaad,{ Patrick Descombes,{ and Olivier Sorg*,†
differentially expressed transcripts were searched with the University of
small fiber peripheral neuropathy (The organs and systems
involved, other than the skin, are just cited here. Each will be
fully addressed in future publications when the mechanism has
been better analyzed by appropriate ongoing data analysis.).
Facial involvement worsened with diffuse nodular lesions on an
edematous background, sparing of the periocular zone, but
major involvement of the ears and retroauricular folds (Figs. 2A
and 2B). The basic skin lesions were small nodules (Fig. 2C),
*Swiss Centre for Applied Human Toxicology, Dermatotoxicology Unit, University of Geneva, 1211 Geneva 4, Switzerland; †Dermatology Department and
‡Radiology Department, Geneva University Hospital, 1211 Geneva 14, Switzerland; §EMPA (Swiss Federal Laboratories for Materials Testing and Research),
8600 Du¨bendorf, Switzerland; and {Genomics Platform, National Center of Competence in Research Frontiers in Genetics, University of Geneva, 1211
Geneva 4, Switzerland
1To whom correspondence should be addressed at Swiss Centre for Applied Human Toxicology, University of Geneva, 1, rue Michel-Servet, 1211 Gene`ve 4,
Switzerland. Fax: 0041-22-379 5502. E-mail: jean.saurat@unige.ch.
Received August 10, 2011; accepted August 10, 2011
Several million people are exposed to dioxin and dioxin-like
compounds, primarily through food consumption. Skin lesions
historically called ‘‘chloracne’’ are the most specific sign of
abnormal dioxin exposure and classically used as a key marker in
humans. We followed for 5 years a man who had been exposed to
the most toxic dioxin, 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD), at a single oral dose of 5 million-fold more than the
accepted daily exposure in the general population. We adopted
a molecular medicine approach, aimed at identifying appropriate
therapy. Skin lesions, which progressively covered up to 40% of
the body surface, were found to be hamartomas, which developed
parallel to a complete and sustained involution of sebaceous
glands, with concurrent transcriptomic alterations pointing to the
inhibition of lipid metabolism and the involvement of bone
morphogenetic proteins signaling. Hamartomas created a new
compartment that concentrated TCDD up to 10-fold compared
with serum and strongly expressed the TCDD-metabolizing
enzyme cytochrome P450 1A1, thus representing a potentially
significant source of enzymatic activity, which may add to the
xenobiotic metabolism potential of the classical organs such as the
liver. This historical case provides a unique set of data on the
human tissue response to dioxin for the identification of new
markers of exposure in human populations. The herein discovered
adaptive cutaneous response to TCDD also points to the potential
role of the skin in the metabolism of food xenobiotics.
Key Words: dioxin; toxicity; skin; hamartoma; morphology.
Dioxin (2,3,7,8-tetrachlorodibenzo-p-dioxin, TCDD) is the
most potent of a large number of industrial-era halogenated
polyaromatic hydrocarbon pollutants, including other dibenzo-p-dioxins,
dibenzofurans, and certain polychlorinated biphenyls.
Human populations are exposed to low levels of dioxin and
dioxin-like compounds, primarily through food consumption
(Connor et al., 2008; Schecter et al., 1999). The risk
characterization of dioxin exposure remains difficult to establish,
although it is an issue that broadly affects important public health
policy decisions (Gies et al., 2007; Steenland et al., 2001). Thus,
chronic exposure to low/moderate doses of dioxin may be
involved not only in the classic dioxin toxicity in some
genetically predisposed individuals (IARC Monograph, 1997;
Aylward et al., 2005) but also in the newly identified role of
these compounds in autoimmunity (Brembilla et al., 2011;
Marshall and Kerkvliet, 2010; Ramirez et al., 2010).
In humans, skin lesions called ‘‘chloracne’’ are the most
visible and consistent response to dioxin exposure and therefore
play the role of a sentinel sign for toxicity (Caputo et al., 1988).
The mechanism by which chloracne appears was not previously
known and its diagnostic value is not straightforward, especially
in mild and sporadic cases, which could still relate to significant
exposure (Passarini et al., 2010). A robust indicator that would
trigger specific ecotoxicology diagnostic processes is lacking; in
the current situation, it is likely that many cases have not been
recognized (Saurat and Sorg, 2010).
We have previously reported on the TCDD poisoning in
Victor Yushchenko with identification and measurement of
TCDD metabolites (Sorg et al., 2009). The maximum accepted
daily dose exposure in human is 4 pg/kg, and this patient
received a single dose of 20 lg/kg.
With the approval of the patient to release peer-reviewed
scientific information on his case, we now report on a set of
data that has never been obtained in humans and helps define
the phenotype of the dioxin-induced skin pathology.
FIG. 1. Evolution of the dioxin disease. Chronology of organ involvement a.p. The peak of skin involvement is delayed as compared with the other organs,
and skin lesions show a longer and chronic course.
MATERIALS AND METHODS
Clinical specimens. Skin sampling was performed under general anesthe-sia
during therapeutic procedures.
! The Author 2011. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved.
For permissions, please email: journals.permissions@oup.com
Downloaded from http://toxsci.oxfordjournals.org/ by guest on October 1, 2014
20
21. SCIENCES 125(1), 310–317 (2012)
Downloaded TOXICOLOGICAL doi:10.1093/toxsci/kfr223
Advance Access publication October 13, 2011
The Cutaneous Lesions of Dioxin Exposure: Lessons from the Poisoning
FROM THE POISONING OF VICTOR YUSHCHENKO 315
sebum lipid
! Downloaded the promoter
and sterol O-acyltransferase
tissue renewing
induced genes,
factor A serine
of the bone
highly relevant to
al., 2006).
from structural/
extracellular matrix’’
expected from
specific pattern.
strongly repressed
involved in the
of Victor Yushchenko
Jean-Hilaire Saurat,*,†,1 Guerkan Kaya,*,† Nikolina Saxer-Sekulic,*,† Bruno Pardo,* Minerva Becker,‡ Lionel Fontao,†
Florence Mottu,*,† Pierre Carraux,† Xuan-Cuong Pham,† Caroline Barde,† Fabienne Fontao,* Markus Zennegg,§
Peter Schmid,§ Olivier Schaad,{ Patrick Descombes,{ and Olivier Sorg*,†
*Swiss Centre for Applied Human Toxicology, Dermatotoxicology Unit, University of Geneva, 1211 Geneva 4, Switzerland; †Dermatology Department and
‡Radiology Department, Geneva University Hospital, 1211 Geneva 14, Switzerland; §EMPA (Swiss Federal Laboratories for Materials Testing and Research),
8600 Du¨bendorf, Switzerland; and {Genomics Platform, National Center of Competence in Research Frontiers in Genetics, University of Geneva, 1211
Geneva 4, Switzerland
1To whom correspondence should be addressed at Swiss Centre for Applied Human Toxicology, University of Geneva, 1, rue Michel-Servet, 1211 Gene`ve 4,
Switzerland. Fax: 0041-22-379 5502. E-mail: jean.saurat@unige.ch.
Received August 10, 2011; accepted August 10, 2011
Several million people are exposed to dioxin and dioxin-like
compounds, primarily through food consumption. Skin lesions
historically called ‘‘chloracne’’ are the most specific sign of
abnormal dioxin exposure and classically used as a key marker in
humans. We followed for 5 years a man who had been exposed to
the most toxic dioxin, 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD), at a single oral dose of 5 million-fold more than the
accepted daily exposure in the general population. We adopted
a molecular medicine approach, aimed at identifying appropriate
therapy. Skin lesions, which progressively covered up to 40% of
the body surface, were found to be hamartomas, which developed
parallel to a complete and sustained involution of sebaceous
glands, with concurrent transcriptomic alterations pointing to the
inhibition of lipid metabolism and the involvement of bone
morphogenetic proteins signaling. Hamartomas created a new
compartment that concentrated TCDD up to 10-fold compared
with serum and strongly expressed the TCDD-metabolizing
enzyme cytochrome P450 1A1, thus representing a potentially
significant source of enzymatic activity, which may add to the
xenobiotic metabolism potential of the classical organs such as the
liver. This historical case provides a unique set of data on the
human tissue response to dioxin for the identification of new
markers of exposure in human populations. The herein discovered
adaptive cutaneous response to TCDD also points to the potential
role of the skin in the metabolism of food xenobiotics.
Key Words: dioxin; toxicity; skin; hamartoma; morphology.
Dioxin (2,3,7,8-tetrachlorodibenzo-p-dioxin, TCDD) is the
most potent of a large number of industrial-era halogenated
polyaromatic hydrocarbon pollutants, including other dibenzo-p-dioxins,
dibenzofurans, and certain polychlorinated biphenyls.
Human populations are exposed to low levels of dioxin and
dioxin-like compounds, primarily through food consumption
(Connor et al., 2008; Schecter et al., 1999). The risk
characterization of dioxin exposure remains difficult to establish,
although it is an issue that broadly affects important public health
policy decisions (Gies et al., 2007; Steenland et al., 2001). Thus,
chronic exposure to low/moderate doses of dioxin may be
involved not only in the classic dioxin toxicity in some
genetically predisposed individuals (IARC Monograph, 1997;
Aylward et al., 2005) but also in the newly identified role of
these compounds in autoimmunity (Brembilla et al., 2011;
Marshall and Kerkvliet, 2010; Ramirez et al., 2010).
In humans, skin lesions called ‘‘chloracne’’ are the most
visible and consistent response to dioxin exposure and therefore
play the role of a sentinel sign for toxicity (Caputo et al., 1988).
The mechanism by which chloracne appears was not previously
known and its diagnostic value is not straightforward, especially
in mild and sporadic cases, which could still relate to significant
exposure (Passarini et al., 2010). A robust indicator that would
trigger specific ecotoxicology diagnostic processes is lacking; in
the current situation, it is likely that many cases have not been
recognized (Saurat and Sorg, 2010).
We have previously reported on the TCDD poisoning in
Victor Yushchenko with identification and measurement of
TCDD metabolites (Sorg et al., 2009). The maximum accepted
daily dose exposure in human is 4 pg/kg, and this patient
received a single dose of 20 lg/kg.
With the approval of the patient to release peer-reviewed
scientific information on his case, we now report on a set of
data that has never been obtained in humans and helps define
the phenotype of the dioxin-induced skin pathology.
MATERIALS AND METHODS
Clinical specimens. Skin sampling was performed under general anesthe-sia
during therapeutic procedures.
from http://toxsci.oxfordjournals.org/ by guest on October 1, 2014
21
22. Compassionate use of tumor necrosis factor a (TNF-a) blockade
was considered because non-steroidal anti-inflammatory drugs and
systemic steroids were not effective. The patient received three
infusions of infliximab but because of intolerancewas then switched
to adalimumab, which was given for M18 (M16th to M34th a.p.).
AL.
! Downloaded FIG. 5. Volumetric analyses of the skin lesions. (A) Three-dimensional
representation of the calculated total skin volume of the face using the
methodology described in the text. (B) Three-dimensional representation of the
calculated volume of the hamartomatous lesions seen in the same area as in (A).
Anterior view. Note that most lesions are located in the ear lobes and lateral
cheeks. (C) Thick slab reconstruction of an FDG PET data set obtained from
a whole-body PET/CT acquisition showing the distribution and the metabolism
org/ by guest on October 1, 2014
TOXICOLOGICAL SCIENCES 125(1), 310–317 (2012)
doi:10.1093/toxsci/kfr223
Advance Access publication October 13, 2011
The Cutaneous Lesions of Dioxin Exposure: Lessons from the Poisoning
of Victor Yushchenko
Jean-Hilaire Saurat,*,†,1 Guerkan Kaya,*,† Nikolina Saxer-Sekulic,*,† Bruno Pardo,* Minerva Becker,‡ Lionel Fontao,†
Florence Mottu,*,† Pierre Carraux,† Xuan-Cuong Pham,† Caroline Barde,† Fabienne Fontao,* Markus Zennegg,§
Peter Schmid,§ Olivier Schaad,{ Patrick Descombes,{ and Olivier Sorg*,†
*Swiss Centre for Applied Human Toxicology, Dermatotoxicology Unit, University of Geneva, 1211 Geneva 4, Switzerland; †Dermatology Department and
‡Radiology Department, Geneva University Hospital, 1211 Geneva 14, Switzerland; §EMPA (Swiss Federal Laboratories for Materials Testing and Research),
8600 Du¨bendorf, Switzerland; and {Genomics Platform, National Center of Competence in Research Frontiers in Genetics, University of Geneva, 1211
Geneva 4, Switzerland
1To whom correspondence should be addressed at Swiss Centre for Applied Human Toxicology, University of Geneva, 1, rue Michel-Servet, 1211 Gene`ve 4,
Switzerland. Fax: 0041-22-379 5502. E-mail: jean.saurat@unige.ch.
Received August 10, 2011; accepted August 10, 2011
Several million people are exposed to dioxin and dioxin-like
compounds, primarily through food consumption. Skin lesions
historically called ‘‘chloracne’’ are the most specific sign of
abnormal dioxin exposure and classically used as a key marker in
humans. We followed for 5 years a man who had been exposed to
the most toxic dioxin, 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD), at a single oral dose of 5 million-fold more than the
accepted daily exposure in the general population. We adopted
a molecular medicine approach, aimed at identifying appropriate
therapy. Skin lesions, which progressively covered up to 40% of
the body surface, were found to be hamartomas, which developed
parallel to a complete and sustained involution of sebaceous
glands, with concurrent transcriptomic alterations pointing to the
inhibition of lipid metabolism and the involvement of bone
morphogenetic proteins signaling. Hamartomas created a new
compartment that concentrated TCDD up to 10-fold compared
with serum and strongly expressed the TCDD-metabolizing
enzyme cytochrome P450 1A1, thus representing a potentially
significant source of enzymatic activity, which may add to the
xenobiotic metabolism potential of the classical organs such as the
liver. This historical case provides a unique set of data on the
human tissue response to dioxin for the identification of new
markers of exposure in human populations. The herein discovered
adaptive cutaneous response to TCDD also points to the potential
role of the skin in the metabolism of food xenobiotics.
Key Words: dioxin; toxicity; skin; hamartoma; morphology.
Dioxin (2,3,7,8-tetrachlorodibenzo-p-dioxin, TCDD) is the
most potent of a large number of industrial-era halogenated
polyaromatic hydrocarbon pollutants, including other dibenzo-p-dioxins,
dibenzofurans, and certain polychlorinated biphenyls.
Human populations are exposed to low levels of dioxin and
dioxin-like compounds, primarily through food consumption
(Connor et al., 2008; Schecter et al., 1999). The risk
characterization of dioxin exposure remains difficult to establish,
although it is an issue that broadly affects important public health
policy decisions (Gies et al., 2007; Steenland et al., 2001). Thus,
chronic exposure to low/moderate doses of dioxin may be
involved not only in the classic dioxin toxicity in some
genetically predisposed individuals (IARC Monograph, 1997;
Aylward et al., 2005) but also in the newly identified role of
these compounds in autoimmunity (Brembilla et al., 2011;
Marshall and Kerkvliet, 2010; Ramirez et al., 2010).
In humans, skin lesions called ‘‘chloracne’’ are the most
visible and consistent response to dioxin exposure and therefore
play the role of a sentinel sign for toxicity (Caputo et al., 1988).
The mechanism by which chloracne appears was not previously
known and its diagnostic value is not straightforward, especially
in mild and sporadic cases, which could still relate to significant
exposure (Passarini et al., 2010). A robust indicator that would
trigger specific ecotoxicology diagnostic processes is lacking; in
the current situation, it is likely that many cases have not been
recognized (Saurat and Sorg, 2010).
We have previously reported on the TCDD poisoning in
Victor Yushchenko with identification and measurement of
TCDD metabolites (Sorg et al., 2009). The maximum accepted
daily dose exposure in human is 4 pg/kg, and this patient
received a single dose of 20 lg/kg.
With the approval of the patient to release peer-reviewed
scientific information on his case, we now report on a set of
data that has never been obtained in humans and helps define
the phenotype of the dioxin-induced skin pathology.
MATERIALS AND METHODS
Clinical specimens. Skin sampling was performed under general anesthe-sia
during therapeutic procedures.
from http://toxsci.oxfordjournals.org/ by guest on October 1, 2014
22
FIG. 3. Histological analyses of the skin lesions. (A) Photomicrograph of
34. pg eq TCDD /
gr échantillon
34
Oui, mais
7 PCDD sur 75
10 PCDF sur 135
12 PBC-dl sur 12
… et les autres ligands ?
… et les synergies ?
35. Au secours
DR CALUX !!!
Dr Heinrich von Calux
1875 - 1910
Peut-on mesure35r
réellement un
Teq TCDD alors ?
36. Dioxin
Receptor
Chemically
Activated
LUciferase gene
eXpression
36
Vous allez
voir, c’est
tout simple
Méthode de biologie
moléculaire de mesure
de l’induction d’un
récepteur par un ligand.
42. GC-HRMS vs DR-CALUX
42
GC-HRMS DR-CALUX
Spécificité +++
Substances
+
Capacité d’activation du
récepteur
Sensibilité ++
1 pg eq TCDD
+++
0.3 pg eq TCDD
Capacité de screening ++
Analyse par substance
+++
Détection des ligands
inconnus
Détection des effets de
synergie (coktail)
Mise en oeuvre Coût : env 1000 CHF
Rapidité : env 15 jours
Coût : env 250 CHF
Rapidité : env 5 jours
Validation Golden Standard Validations, food, sang, terres,
poussières, eaux.
43. Exemples d’application du DR CALUX en
hygiène du travail
Suivi des expositions des travailleurs lors des travaux de
sécurisation d’un site contaminé aux PCB.
43
44. Mesure de la perméation des PCB
indicateurs dans les combinaisons
45. Suivi sanguin DR-CALUX
analyse Teq TCDD sang
A (avant travaux):
21.8 +/- 5.03 pg TCDD TEQ/g fat
B: (après travaux):
19.9 +/- 6.42 pg TCDD TEQ/g fat
Pas de différence statistiquement significative
entre les 2 séries (Wilcoxon signed rank test,
paired values)
No patient
1
2
3
4
5
6
7
8
9
10
Average
Median
Standard deviation
Coeff. of variation
Minimum
Maximum
Range
Stnd. skewness
Stnd. kurtosis
CALUX A
PCDD/PCDF and dl-
PCBs (only total TEQ)
[pg TEQ/g fat]
CALUX B
PCDD/PCDF and dl-
PCBs (only total TEQ)
[pg TEQ/g fat]
19* 29
28 25
32 18
20 16
24 16
20 13
16* 17
23 21
19 31
17 13
21.8 19.9
20 17.5
5.03 6.42
0.23 0.32
16 13
32 31
16 18
1.34 0.98
0.31 -0.50
(*) < LOQ
Concentrations usuelles dans le sérum
(publications)
Non exposé ou nouveau né:
23 to 27 pg TCDD TEQ/g fat
Habitant proche d’une usine d’incinération
55 to 76 pg TCDD TEQ/g fat
T0 T+4 mois
45
46. Exemples d’application du DR CALUX en
environnement
Analyse des PCB dans des éléments en amiante-ciment
46
49. Exemples d’application du DR CALUX en
hygiène du travail
Contamination des surfaces de travail aux composés Dioxin-like
dans un incinérateur municipal
50. 50
Prélèvement des surfaces (wipe-test)
TOXpro 2014, unpublished data
Valeurs seuils
Allemagne
10 ng/m2
54. 54
Brommer et al. J
Environ Monitor
2012;
Marklund et al.
Chemosphere 2003;
Stapleton et al.
Environ Sci Technol
2005;2009;
Takigami et al.
Environ Int 2009; Van
den Eede et al.
Environ Int 2011
55. profiles to in vivo toxicity of the compounds?
La gamme des récepteurs et « pathway) 55
compound ‘profile’
Compound
CALUX assays currently available:
Nuclear receptors Signaling pathways
name endpoint name endpoint
DR CALUX dioxins NFκB CALUX inflammation
PAH CALUX PAHs p21 CALUX DNA damage
ERα CALUX estrogens Nrf2 CALUX oxid. stress
ERβ CALUX estrogens p53 CALUX DNA damage
AR CALUX androgens TCF CALUX carcinogenesis
PR CALUX progestins AP1 CALUX stress
GR CALUX glucocortocoid HIF1α CALUX hypoxia
TRβ CALUX thyroids ESRE CALUX ER stress
RAR CALUX retinoids Cytotox CALUX cytotoxicity
PPARγ CALUX obesogens
PPARα CALUX obesogens
PPARδ CALUX obesogens
PXR CALUX xenobiotics
LXR CALUX oxysterols